BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 31393855)

  • 1. Fibroblast-specific deletion of interleukin-1 receptor-1 reduces adverse cardiac remodeling following myocardial infarction.
    Bageghni SA; Hemmings KE; Yuldasheva NY; Maqbool A; Gamboa-Esteves FO; Humphreys NE; Jackson MS; Denton CP; Francis S; Porter KE; Ainscough JF; Pinteaux E; Drinkhill MJ; Turner NA
    JCI Insight; 2019 Aug; 5(17):. PubMed ID: 31393855
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interleukin-1α dependent survival of cardiac fibroblasts is associated with StAR/STARD1 expression and improved cardiac remodeling and function after myocardial infarction.
    Razin T; Melamed-Book N; Argaman J; Galin I; Lowy Y; Anuka E; Naftali-Shani N; Kandel-Kfir M; Garfinkel BP; Brielle S; Granot Z; Apte RN; Conway SJ; Molkentin JD; Kamari Y; Leor J; Orly J
    J Mol Cell Cardiol; 2021 Jun; 155():125-137. PubMed ID: 33130150
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The systemic deletion of interleukin-1α reduces myocardial inflammation and attenuates ventricular remodeling in murine myocardial infarction.
    Lugrin J; Parapanov R; Milano G; Cavin S; Debonneville A; Krueger T; Liaudet L
    Sci Rep; 2023 Mar; 13(1):4006. PubMed ID: 36899010
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reduced cardiac remodeling and function in cardiac-specific EP4 receptor knockout mice with myocardial infarction.
    Qian JY; Harding P; Liu Y; Shesely E; Yang XP; LaPointe MC
    Hypertension; 2008 Feb; 51(2):560-6. PubMed ID: 18180401
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Myeloid interleukin-4 receptor α is essential in postmyocardial infarction healing by regulating inflammation and fibrotic remodeling.
    Song J; Frieler RA; Whitesall SE; Chung Y; Vigil TM; Muir LA; Ma J; Brombacher F; Goonewardena SN; Lumeng CN; Goldstein DR; Mortensen RM
    Am J Physiol Heart Circ Physiol; 2021 Jan; 320(1):H323-H337. PubMed ID: 33164548
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IL-17A promotes ventricular remodeling after myocardial infarction.
    Zhou SF; Yuan J; Liao MY; Xia N; Tang TT; Li JJ; Jiao J; Dong WY; Nie SF; Zhu ZF; Zhang WC; Lv BJ; Xiao H; Wang Q; Tu X; Liao YH; Shi GP; Cheng X
    J Mol Med (Berl); 2014 Oct; 92(10):1105-16. PubMed ID: 24965614
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Deficiency of Capn4 gene inhibits nuclear factor-κB (NF-κB) protein signaling/inflammation and reduces remodeling after myocardial infarction.
    Ma J; Wei M; Wang Q; Li J; Wang H; Liu W; Lacefield JC; Greer PA; Karmazyn M; Fan GC; Peng T
    J Biol Chem; 2012 Aug; 287(33):27480-9. PubMed ID: 22753411
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adipolin/C1q/Tnf-related protein 12 prevents adverse cardiac remodeling after myocardial infarction.
    Takikawa T; Ohashi K; Ogawa H; Otaka N; Kawanishi H; Fang L; Ozaki Y; Eguchi S; Tatsumi M; Takefuji M; Murohara T; Ouchi N
    PLoS One; 2020; 15(12):e0243483. PubMed ID: 33275602
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alterations in the interleukin-1/interleukin-1 receptor antagonist balance modulate cardiac remodeling following myocardial infarction in the mouse.
    Abbate A; Salloum FN; Van Tassell BW; Vecile E; Toldo S; Seropian I; Mezzaroma E; Dobrina A
    PLoS One; 2011; 6(11):e27923. PubMed ID: 22140485
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nicotinamide riboside kinase-2 alleviates ischemia-induced heart failure through P38 signaling.
    Ahmad F; Tomar D; Aryal A C S; Elmoselhi AB; Thomas M; Elrod JW; Tilley DG; Force T
    Biochim Biophys Acta Mol Basis Dis; 2020 Mar; 1866(3):165609. PubMed ID: 31743747
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of fibroblast IL-6 production by ACKR4 deletion alleviates cardiac remodeling after myocardial infarction.
    Zhang M; Zhang M; Zhou T; Liu M; Xia N; Gu M; Tang T; Nie S; Zhu Z; Lv B; Jiao J; Yang X; Cheng X
    Biochem Biophys Res Commun; 2021 Apr; 547():139-147. PubMed ID: 33610913
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Class A scavenger receptor attenuates myocardial infarction-induced cardiomyocyte necrosis through suppressing M1 macrophage subset polarization.
    Hu Y; Zhang H; Lu Y; Bai H; Xu Y; Zhu X; Zhou R; Ben J; Xu Y; Chen Q
    Basic Res Cardiol; 2011 Nov; 106(6):1311-28. PubMed ID: 21769674
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiomyocyte-specific deficiency of HSPB1 worsens cardiac dysfunction by activating NFκB-mediated leucocyte recruitment after myocardial infarction.
    Wang Y; Liu J; Kong Q; Cheng H; Tu F; Yu P; Liu Y; Zhang X; Li C; Li Y; Min X; Du S; Ding Z; Liu L
    Cardiovasc Res; 2019 Jan; 115(1):154-167. PubMed ID: 29982352
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiomyocyte-specific deletion of β-catenin protects mouse hearts from ventricular arrhythmias after myocardial infarction.
    Wang J; Xia Y; Lu A; Wang H; Davis DR; Liu P; Beanlands RS; Liang W
    Sci Rep; 2021 Sep; 11(1):17722. PubMed ID: 34489488
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Toll-like receptor 7 deficiency promotes survival and reduces adverse left ventricular remodelling after myocardial infarction.
    de Kleijn DPV; Chong SY; Wang X; Yatim SMJM; Fairhurst AM; Vernooij F; Zharkova O; Chan MY; Foo RSY; Timmers L; Lam CSP; Wang JW
    Cardiovasc Res; 2019 Oct; 115(12):1791-1803. PubMed ID: 30830156
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiac FGF23: new insights into the role and function of FGF23 after acute myocardial infarction.
    Schumacher D; Alampour-Rajabi S; Ponomariov V; Curaj A; Wu Z; Staudt M; Rusu M; Jankowski V; Marx N; Jankowski J; Brandenburg V; Liehn EA; Schuh A
    Cardiovasc Pathol; 2019; 40():47-54. PubMed ID: 30852297
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Amphiregulin enhances cardiac fibrosis and aggravates cardiac dysfunction in mice with experimental myocardial infarction partly through activating EGFR-dependent pathway.
    Liu L; Jin X; Hu CF; Zhang YP; Zhou Z; Li R; Shen CX
    Basic Res Cardiol; 2018 Jan; 113(2):12. PubMed ID: 29349588
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiomyocyte-specific deletion of Gsk3α mitigates post-myocardial infarction remodeling, contractile dysfunction, and heart failure.
    Ahmad F; Lal H; Zhou J; Vagnozzi RJ; Yu JE; Shang X; Woodgett JR; Gao E; Force T
    J Am Coll Cardiol; 2014 Aug; 64(7):696-706. PubMed ID: 25125302
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Absence of Myostatin Improves Cardiac Function Following Myocardial Infarction.
    Lim S; McMahon CD; Matthews KG; Devlin GP; Elston MS; Conaglen JV
    Heart Lung Circ; 2018 Jun; 27(6):693-701. PubMed ID: 28690022
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Deficiency of mouse mast cell protease 4 mitigates cardiac dysfunctions in mice after myocardium infarction.
    Wang Y; Liu CL; Fang W; Zhang X; Yang C; Li J; Liu J; Sukhova GK; Gurish MF; Libby P; Shi GP; Zhang J
    Biochim Biophys Acta Mol Basis Dis; 2019 Jun; 1865(6):1170-1181. PubMed ID: 30639224
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.